QIAGEN Expands Clinical Decision Support for NGS in Oncology Labs
Adding solutions to QIAGEN Clinical Insight® for hereditary cancers and more somatic cancers
Adding solutions to QIAGEN Clinical Insight® for hereditary cancers and more somatic cancers
World's largest medical trade fair starts in Dusseldorf in two weeks time
Cloud genomics platform facilitates end-to-end solution for clinical research
Booth 1415
Researchers present data at breast cancer symposium showing MammaPrint/BluePrint can identify women who benefit from chemotherapy and targeted dual anti-HER2 drug treatment before surgery
Discover our latest clinical content
Biomedical scientists from around the world congregate at the IBMS Congress
Smokers who survive their habit into old age may hold the key to better lung health for all, according to a study funded by the Medical Research Council (MRC)
Dr Emilio Diez-Monedero explains the current approach to molecular drug discovery and gives SelectScience a sneak peek into the SLAS Spanish Drug Discovery Network Meeting
Through advanced genetic algorithms and supercomputing, scientists have discovered how genetic diseases such as cancer systematically attack the networks controlling human cells, according to a pair of papers published back-to-back in CELL.
New whitepaper demonstrates how customizable, medically focused array designs complement NGS for clinical genetics research
Early identification of the disease will allow specific and extremely effective therapies for the treatment of patients
The CEO of EKF Molecular discusses the use of PointMan technology in recent clinical studies
AMSBIO has introduced an expanded range of Adeno-associated virus (AAV) cloning and packaging services
Educational workshops, new diagnostics platforms address critical factors for lab success